X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Johnson & Johnson baby powder/Photo: Raihana Asral/Shutterstock.com

A second jury in two weeks has failed to reach a verdict in a trial alleging Johnson & Johnson’s baby powder caused mesothelioma.

Los Angeles Superior Court Judge Stephen Maloney declared a mistrial on Tuesday, the third day of jury deliberations in a trial that began about a month ago. The mistrial comes a little over a week after another jury deadlocked in a separate trial against Johnson & Johnson involving the same Dallas-based plaintiffs firm, Simon Greenstone Panatier. In that case, Los Angeles Superior Court Judge Margaret Oldendorf declared a mistrial following a week of deliberations and numerous efforts to assist the jury in reaching a verdict.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Amanda Bronstad

Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Critical Mass. She is based in Los Angeles.

More from this author

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

Drug and Medical Device Product Liability DeskbookBook

This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.

Get More Information
 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.